148 related articles for article (PubMed ID: 26232066)
1. Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders.
Wang C; Wang HF; Tan MS; Liu Y; Jiang T; Zhang DQ; Tan L; Yu JT;
Mol Neurobiol; 2016 Sep; 53(7):4343-51. PubMed ID: 26232066
[TBL] [Abstract][Full Text] [Related]
2. Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.
Wang C; Tan L; Wang HF; Yu WJ; Liu Y; Jiang T; Tan MS; Hao XK; Zhang DQ; Yu JT;
J Alzheimers Dis; 2015; 46(2):491-5. PubMed ID: 26402410
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
[TBL] [Abstract][Full Text] [Related]
4. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
Langbaum JB; Chen K; Lee W; Reschke C; Bandy D; Fleisher AS; Alexander GE; Foster NL; Weiner MW; Koeppe RA; Jagust WJ; Reiman EM;
Neuroimage; 2009 May; 45(4):1107-16. PubMed ID: 19349228
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
[TBL] [Abstract][Full Text] [Related]
6. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
7. Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
Chen X; Zhou Y; Wang R; Cao H; Reid S; Gao R; Han D;
PLoS One; 2016; 11(5):e0154406. PubMed ID: 27183116
[TBL] [Abstract][Full Text] [Related]
8. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345
[TBL] [Abstract][Full Text] [Related]
9. Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts.
Zhu XC; Wang HF; Jiang T; Lu H; Tan MS; Tan CC; Tan L; Tan L; Yu JT;
Mol Neurobiol; 2017 Jan; 54(1):551-562. PubMed ID: 26742530
[TBL] [Abstract][Full Text] [Related]
10. Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort.
Tan MS; Wang P; Ma FC; Li JQ; Tan CC; Yu JT; Tan L;
J Alzheimers Dis; 2018; 65(3):871-876. PubMed ID: 30103332
[TBL] [Abstract][Full Text] [Related]
11. Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease.
Hao X; Yao X; Yan J; Risacher SL; Saykin AJ; Zhang D; Shen L;
Neuroinformatics; 2016 Oct; 14(4):439-52. PubMed ID: 27277494
[TBL] [Abstract][Full Text] [Related]
12. Correlation Between Brain 18F-AV45 and 18F-FDG PET Distribution Characteristics and Cognitive Function in Patients with Mild and Moderate Alzheimer's Disease.
Jing J; Zhang F; Zhao L; Xie J; Chen J; Zhong R; Zhang Y; Dong C
J Alzheimers Dis; 2021; 79(3):1317-1325. PubMed ID: 33427748
[TBL] [Abstract][Full Text] [Related]
13. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
14. Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares.
Wang P; Chen K; Yao L; Hu B; Wu X; Zhang J; Ye Q; Guo X;
J Alzheimers Dis; 2016 Aug; 54(1):359-71. PubMed ID: 27567818
[TBL] [Abstract][Full Text] [Related]
15. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
[TBL] [Abstract][Full Text] [Related]
16. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
[TBL] [Abstract][Full Text] [Related]
17. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia.
Arbizu J; Prieto E; Martínez-Lage P; Martí-Climent JM; García-Granero M; Lamet I; Pastor P; Riverol M; Gómez-Isla MT; Peñuelas I; Richter JA; Weiner MW;
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1394-405. PubMed ID: 23715905
[TBL] [Abstract][Full Text] [Related]
18. Glucose hypometabolism in the Auditory Pathway in Age Related Hearing Loss in the ADNI cohort.
Zainul Abidin FN; Scelsi MA; Dawson SJ; Altmann A;
Neuroimage Clin; 2021; 32():102823. PubMed ID: 34624637
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association study identifies
Li X; Chu SG; Shen XN; Hou XH; Xu W; Ou YN; Dong Q; Tan L; Yu JT
Aging (Albany NY); 2019 Nov; 11(21):9862-9874. PubMed ID: 31711042
[TBL] [Abstract][Full Text] [Related]
20. PLD3 in Alzheimer's Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses.
Zhang DF; Fan Y; Wang D; Bi R; Zhang C; Fang Y; Yao YG
Mol Neurobiol; 2016 Aug; 53(6):4034-4045. PubMed ID: 26189833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
